Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

(2014) J. Newcorn et al.   EUROPEAN PSYCHIATRY

EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study

(2014) A. Hervas et al.   EUROPEAN PSYCHIATRY

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design

(2014) David R. Coghill et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder

(2013) Tobias Banaschewski et al.   CNS DRUGS

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

(2013) Ralf W. Dittmann et al.   CNS DRUGS

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

(2013) David Coghill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

(2013) Robert L. Findling et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Randomized, Double-Blind Trial of Guanfacine Extended Release in Children With Attention-Deficit/Hyperactivity Disorder: Morning or Evening Administration

(2013) Jeffrey H. Newcorn et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Development of a conceptual disease model to inform strategy to evaluate treatment impact in adolescents with attention deficit hyperactivity disorder (ADHD)

(2013) R. Pokrzywinski et al.   VALUE IN HEALTH

Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder

(2012) Richard H. Weisler et al.   CNS DRUGS

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2012) Matthew Brams et al.   JOURNAL OF CLINICAL PSYCHIATRY

Quality of life and psychomotor profile of children with attention deficit hyperactivity disorder (ADHD)

(2011) Juliana Barbosa Goulardins et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD

(2011) Andreas Becker et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Relationship between symptoms of attention-deficit/hyperactivity disorder and family functioning: a community-based study

(2011) Alexandra Cussen et al.   EUROPEAN JOURNAL OF PEDIATRICS

Dose Effects and Comparative Effectiveness of Extended Release Dexmethylphenidate and Mixed Amphetamine Salts

(2011) Mark A. Stein et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

(2011) Robert L. Findling et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Clonidine Extended-Release Tablets for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder

(2011) Rakesh Jain et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder

(2011) Timothy E. Wilens et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD

(2011) S. H. Kollins et al.   PEDIATRICS

The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

(2011) S. Bernardi et al.   PSYCHOLOGICAL MEDICINE

Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

(2010) Peter M. Wehmeier et al.   JOURNAL OF ADOLESCENT HEALTH

Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms

(2010) Rodrigo Escobar et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov

(2009) John F. Scoggins et al.   Contemporary Clinical Trials

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

(2009) Marina Danckaerts et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies

(2009) Erik Parens et al.   Child and Adolescent Psychiatry and Mental Health